These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 31694837)

  • 1. Association of macular disease with long-term use of pentosan polysulfate sodium: findings from a US cohort.
    Jain N; Li AL; Yu Y; VanderBeek BL
    Br J Ophthalmol; 2020 Aug; 104(8):1093-1097. PubMed ID: 31694837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pentosan Polysulfate Sodium Exposure and Drug-Induced Maculopathy in Commercially Insured Patients in the United States.
    Ludwig CA; Vail D; Callaway NF; Pasricha MV; Moshfeghi DM
    Ophthalmology; 2020 Apr; 127(4):535-543. PubMed ID: 31899034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease Course in Patients With Pentosan Polysulfate Sodium-Associated Maculopathy After Drug Cessation.
    Shah R; Simonett JM; Lyons RJ; Rao RC; Pennesi ME; Jain N
    JAMA Ophthalmol; 2020 Aug; 138(8):894-900. PubMed ID: 32644147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PENTOSAN POLYSULFATE AND VISION: Findings from an International Survey of Exposed Individuals.
    Uner OE; Shah MK; Jain N
    Retina; 2021 Jul; 41(7):1562-1569. PubMed ID: 33332810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanded Clinical Spectrum of Pentosan Polysulfate Maculopathy: A Macula Society Collaborative Study.
    Jain N; Liao A; Garg SJ; Patel SN; Wykoff CC; Yu HJ; London NJS; Khurana RN; Zacks DN;
    Ophthalmol Retina; 2022 Mar; 6(3):219-227. PubMed ID: 34298229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentosan polysulfate maculopathy.
    Lindeke-Myers A; Hanif AM; Jain N
    Surv Ophthalmol; 2022; 67(1):83-96. PubMed ID: 34000253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pigmentary Maculopathy Associated with Chronic Exposure to Pentosan Polysulfate Sodium.
    Pearce WA; Chen R; Jain N
    Ophthalmology; 2018 Nov; 125(11):1793-1802. PubMed ID: 29801663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of maculopathy with pentosan polysulfate sodium use.
    Bae SS; Sodhi M; Maberley D; Kezouh A; Etminan M
    Br J Clin Pharmacol; 2022 Jul; 88(7):3428-3433. PubMed ID: 35277990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentosan Polysulfate Maculopathy versus Inherited Macular Dystrophies: Comparative Assessment with Multimodal Imaging.
    Barnes AC; Hanif AM; Jain N
    Ophthalmol Retina; 2020 Dec; 4(12):1196-1201. PubMed ID: 32446908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentosan-associated maculopathy: prevalence, screening guidelines, and spectrum of findings based on prospective multimodal analysis.
    Wang D; Au A; Gunnemann F; Hilely A; Scharf J; Tran K; Sun M; Kim JH; Sarraf D
    Can J Ophthalmol; 2020 Apr; 55(2):116-125. PubMed ID: 31973791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pentosan Polysulfate Maculopathy: Prevalence, Spectrum of Disease, and Choroidal Imaging Analysis Based on Prospective Screening.
    Wang D; Velaga SB; Grondin C; Au A; Nittala M; Chhablani J; Vupparaboina KK; Gunnemann F; Jung J; Kim JH; Ip M; Sadda S; Sarraf D
    Am J Ophthalmol; 2021 Jul; 227():125-138. PubMed ID: 33651989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-Related Macular Degeneration Masquerade: A Review of Pentosan Polysulfate Maculopathy and Implications for Clinical Practice.
    Mukhopadhyay C; Boyce TM; Gehrs KM; Folk JC; Mullins RF; Luo Y; Kreder K; Sohn EH
    Asia Pac J Ophthalmol (Phila); 2022 Mar-Apr 01; 11(2):100-110. PubMed ID: 35533330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case Report: Pentosan Polysulfate Sodium Maculopathy Originally Diagnosed as Pattern Macular Dystrophy.
    Case AW; Anderson MJ; Sayomac LE
    Optom Vis Sci; 2021 Jun; 98(6):552-556. PubMed ID: 34039907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentosan polysulfate and a pigmentary maculopathy: causation versus correlation?
    Proctor JG
    Can J Urol; 2023 Dec; 30(6):11732-11739. PubMed ID: 38104330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association Between Pentosan Polysulfate Sodium and Retinal Disorders.
    McGwin G; MacLennan P; Owsley C
    JAMA Ophthalmol; 2022 Jan; 140(1):37-42. PubMed ID: 34792558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pentosan polysulfate maculopathy versus age-related macular degeneration: comparative assessment with multimodal imaging.
    Christiansen JS; Barnes AC; Berry DE; Jain N
    Can J Ophthalmol; 2022 Feb; 57(1):16-22. PubMed ID: 33722504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive Maculopathy After Discontinuation of Pentosan Polysulfate Sodium.
    Huckfeldt RM; Vavvas DG
    Ophthalmic Surg Lasers Imaging Retina; 2019 Oct; 50(10):656-659. PubMed ID: 31671200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening practices and risk assessment for maculopathy in pentosan polysulfate users across different exposure levels.
    Kwon HY; Kim J; Ahn SJ
    Sci Rep; 2024 May; 14(1):11270. PubMed ID: 38760453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-Year Outcomes After Variable Duration of Drug Cessation in Patients With Maculopathy Associated With Pentosan Polysulfate Use.
    Jung EH; Lindeke-Myers A; Jain N
    JAMA Ophthalmol; 2023 Mar; 141(3):260-266. PubMed ID: 36729449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macular Findings of Patients on Pentosan Polysulfate Sodium.
    Blackorby BL; Banda H; Smith BT; Shah GK
    Mil Med; 2023 Mar; 188(3-4):e579-e583. PubMed ID: 34296258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.